Correlation Between Sp Midcap and Biotechnology Fund
Can any of the company-specific risk be diversified away by investing in both Sp Midcap and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sp Midcap and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sp Midcap 400 and Biotechnology Fund Class, you can compare the effects of market volatilities on Sp Midcap and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sp Midcap with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sp Midcap and Biotechnology Fund.
Diversification Opportunities for Sp Midcap and Biotechnology Fund
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between RYBHX and Biotechnology is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Sp Midcap 400 and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Sp Midcap is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sp Midcap 400 are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Sp Midcap i.e., Sp Midcap and Biotechnology Fund go up and down completely randomly.
Pair Corralation between Sp Midcap and Biotechnology Fund
Assuming the 90 days horizon Sp Midcap 400 is expected to generate 0.82 times more return on investment than Biotechnology Fund. However, Sp Midcap 400 is 1.22 times less risky than Biotechnology Fund. It trades about 0.39 of its potential returns per unit of risk. Biotechnology Fund Class is currently generating about 0.0 per unit of risk. If you would invest 5,593 in Sp Midcap 400 on September 2, 2024 and sell it today you would earn a total of 584.00 from holding Sp Midcap 400 or generate 10.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sp Midcap 400 vs. Biotechnology Fund Class
Performance |
| Timeline |
| Sp Midcap 400 |
| Biotechnology Fund Class |
Sp Midcap and Biotechnology Fund Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sp Midcap and Biotechnology Fund
The main advantage of trading using opposite Sp Midcap and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sp Midcap position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.| Sp Midcap vs. Sp Smallcap 600 | Sp Midcap vs. Sp 500 Pure | Sp Midcap vs. Sp Midcap 400 | Sp Midcap vs. Sp Smallcap 600 |
| Biotechnology Fund vs. Baron Health Care | Biotechnology Fund vs. Alger Health Sciences | Biotechnology Fund vs. The Hartford Healthcare | Biotechnology Fund vs. Allianzgi Health Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |